Post Tagged with: "PTLA"

Morning Buzz: Portola Pharmaceuticals (NASDAQ:PTLA), Denbury Resources (NYSE:DNR), Canadian Imperial Bank of Commerce (NYSE:CM), Fortune Brands Home & Security (NYSE:FBHS), PAHC

April 16, 2015 at 1:33 pm 0 comments

On Wednesday shares of Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) closed at $39.45. On 8 April, Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) announced positive topline results from the second part of the Phase 3 ANNEXA™-A study, which evaluated the safety and efficacy of andRead More

Trending Tickers: Culp (NYSE:CFI), Portola Pharmaceuticals (NASDAQ:PTLA), Zynga Inc (NASDAQ:ZNGA), Owens-Illinois (NYSE:OI), Sohu.com Inc. (NASDAQ:SOHU)

April 14, 2015 at 2:46 pm 0 comments

On Monday shares of Culp, Inc. (NYSE:CFI) closed at $26.50. Company’s sales growth for last 5 years was 7.10% and EPS growth for next 5 years is recorded as 9.00%. Culp, Inc. (NYSE:CFI) was downgraded by stock analysts at RaymondRead More

Trader’s Watch List: Epizyme (NASDAQ:EPZM), Yandex N.V. (NASDAQ:YNDX), Citigroup Inc. (NYSE:C), Portola Pharmaceuticals (NASDAQ:PTLA), Frontline (NYSE:FRO)

April 14, 2015 at 2:41 pm 0 comments

On Monday shares of Epizyme, Inc. (NASDAQ:EPZM) closed at $19.74. Epizyme, Inc. (NASDAQ:EPZM) announced that data from its preclinical pipeline will be presented during the American Association for Cancer Research (AACR) Annual Meeting, to be held April 18-25 in Philadelphia,Read More

Worth Watching Stocks: Portola Pharmaceuticals (NASDAQ:PTLA), Groupon (NASDAQ:GRPN), Biogen Inc. (NASDAQ:BIIB), Ford Motor Company (NYSE:F), 3M Company (NYSE:MMM)

April 6, 2015 at 1:15 pm 0 comments

On Thursday shares of Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) closed at $37.24. Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) had its target price boosted by Credit Suisse to $51.00 in a report issued on Tuesday. Groupon, Inc. (NASDAQ:GRPN) in last trading activity increased 0.57%Read More

Traders Buzz: United States Steel Corp. (NYSE:X), Portola Pharmaceuticals (NASDAQ:PTLA), Union Pacific Corporation (NYSE:UNP), Redwood Trust (NYSE:RWT), YRC Worldwide (NASDAQ:YRCW)

March 13, 2015 at 1:28 pm 0 comments

United States Steel Corporation (NYSE:X) announced it will temporarily idle its Minnesota Ore Operations – Keetac plant in Keewatin, Minn., effective May 13. The temporary idling is due to the company’s current inventory levels and ongoing adjustment of its steelmakingRead More

Stay on: ICICI Bank (NYSE:IBN), IAMGOLD Corp. (NYSE:IAG), Portola Pharmaceuticals (NASDAQ:PTLA), EMC Corporation (NYSE:EMC), UIL Holdings Corporation (NYSE:UIL)

February 27, 2015 at 1:19 pm 0 comments

ICICI Bank Ltd. (NYSE:IBN) has invited online applications for its Probationary Officer training programme. There will be two batches that will start undergoing the training at the ICICI Manipal Academy for Banking and Insurance (IMA) in the first week ofRead More

Top Stocks: 500.com Limited (NYSE:WBAI), J C Penney Company Inc (NYSE:JCP), Portola Pharmaceuticals (NASDAQ:PTLA), Prudential Bancorp (NASDAQ:PBIP), The Dow Chemical (NYSE:DOW)

February 26, 2015 at 3:10 pm 0 comments

500.com Limited (NYSE:WBAI) announced that it had recently come to the Company’s attention that certain provincial sports lottery administration centers to which the Company provides sport lottery sales services plan to temporarily suspend accepting online purchase orders for lottery products,Read More

Biotech Gainers in Spotlight: Genetic Technologies Limited (NASDAQ:GENE), Cambrex Corporation. (NYSE:CBM), Portola Pharmaceuticals (NASDAQ:PTLA), Coherus Biosciences (NASDAQ:CHRS), Vericel Corporation (NASDAQ:VCEL)

February 9, 2015 at 12:38 pm 0 comments

On 29 January, Genetic Technologies Limited (NASDAQ: GENE) reported that up to 6 new breast diagnosis/treatment centres are expected to begin offering BREVAGenplus® to their at-risk patients in a systematic broad fashion in the January to March timeframe, with aRead More

Mix Sector Stocks: BlackBerry Ltd (NASDAQ:BBRY), Kinder Morgan (NYSE:KMI), SM Energy Company (NYSE:SM), Microsemi Corporation (NASDAQ:MSCC), Portola Pharmaceuticals (NASDAQ:PTLA)

February 8, 2015 at 3:51 pm 0 comments

On 26 January, BlackBerry Ltd (NASDAQ:BBRY) said that Samsung Electronics offered to buy BlackBerry Ltd for as much as $7.5 billion. On Friday shares of BlackBerry Ltd (NASDAQ:BBRY) closed at $9.98. Company’s sales growth for last 5 years was -9.20%Read More

Market Watch List: Portola Pharmaceuticals (NASDAQ:PTLA), Opko Health (NYSE:OPK), Bellatrix Exploration (NYSE:BXE), Konami Corp. (NYSE:KNM), Steiner Leisure (NASDAQ:STNR)

February 7, 2015 at 3:19 pm 0 comments

Portola Pharmaceuticals (Nasdaq:PTLA) announced that the Independent Data Monitoring Committee (IDMC) recommended that the Phase 3 APEX (Acute Medically Ill VTE Prevention with Extended Duration Betrixaban) Study of betrixaban continue as planned without modification based on the successful completion ofRead More